DrugCite
Search

METHYLPREDNISOLONE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Methylprednisolone Adverse Events Reported to the FDA Over Time

How are Methylprednisolone adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Methylprednisolone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Methylprednisolone is flagged as the suspect drug causing the adverse event.

Most Common Methylprednisolone Adverse Events Reported to the FDA

What are the most common Methylprednisolone adverse events reported to the FDA?

Pyrexia
498 (1.06%)
Dyspnoea
455 (.96%)
Drug Ineffective
387 (.82%)
Sepsis
346 (.73%)
Headache
338 (.72%)
Cytomegalovirus Infection
336 (.71%)
Nausea
313 (.66%)
Pneumonia
311 (.66%)
Respiratory Failure
299 (.63%)
Condition Aggravated
293 (.62%)
Thrombocytopenia
271 (.57%)
Show More Show More
Vomiting
266 (.56%)
Multi-organ Failure
264 (.56%)
Diarrhoea
253 (.54%)
Anaemia
250 (.53%)
Neutropenia
240 (.51%)
Hypertension
231 (.49%)
Asthenia
225 (.48%)
Renal Failure
219 (.46%)
Hypotension
212 (.45%)
Malaise
212 (.45%)
Pain
212 (.45%)
Abdominal Pain
203 (.43%)
Erythema
203 (.43%)
Osteonecrosis
198 (.42%)
Rash
198 (.42%)
Diabetes Mellitus
194 (.41%)
Hypersensitivity
184 (.39%)
Pruritus
184 (.39%)
Fatigue
177 (.38%)
Blood Pressure Increased
174 (.37%)
Convulsion
174 (.37%)
Arthralgia
167 (.35%)
Septic Shock
166 (.35%)
Back Pain
165 (.35%)
Urticaria
161 (.34%)
Interstitial Lung Disease
159 (.34%)
Dizziness
158 (.34%)
Depression
157 (.33%)
Renal Impairment
157 (.33%)
Tachycardia
157 (.33%)
Pain In Extremity
152 (.32%)
Anxiety
150 (.32%)
Transplant Rejection
150 (.32%)
Cardiac Arrest
146 (.31%)
Loss Of Consciousness
145 (.31%)
Multiple Sclerosis Relapse
143 (.3%)
Haemoglobin Decreased
140 (.3%)
Tendon Rupture
140 (.3%)
Hyperglycaemia
139 (.29%)
Anaphylactic Shock
134 (.28%)
Chest Pain
134 (.28%)
Hypoaesthesia
134 (.28%)
Pleural Effusion
134 (.28%)
Aspergillosis
133 (.28%)
General Physical Health Deteriorati...
133 (.28%)
Blood Glucose Increased
132 (.28%)
Acute Respiratory Distress Syndrome
130 (.28%)
Infection
130 (.28%)
Renal Failure Acute
130 (.28%)
Confusional State
129 (.27%)
Weight Increased
129 (.27%)
Atrial Fibrillation
128 (.27%)
Drug Interaction
128 (.27%)
Platelet Count Decreased
128 (.27%)
Oedema Peripheral
127 (.27%)
Kidney Transplant Rejection
125 (.27%)
Staphylococcal Infection
124 (.26%)
Paraesthesia
123 (.26%)
Respiratory Distress
123 (.26%)
Hepatic Function Abnormal
122 (.26%)
Tremor
122 (.26%)
Anaphylactic Reaction
121 (.26%)
Blood Pressure Decreased
121 (.26%)
Gastrointestinal Haemorrhage
121 (.26%)
Pneumocystis Jiroveci Pneumonia
121 (.26%)
Aspartate Aminotransferase Increase...
120 (.25%)
Blood Creatinine Increased
120 (.25%)
Weight Decreased
120 (.25%)
Chills
118 (.25%)
Hyperhidrosis
117 (.25%)
Muscular Weakness
116 (.25%)
Pancytopenia
114 (.24%)
Alanine Aminotransferase Increased
112 (.24%)
Insomnia
112 (.24%)
Urinary Tract Infection
112 (.24%)
Fall
111 (.24%)
Tendonitis
110 (.23%)
Death
108 (.23%)
Flushing
108 (.23%)
Drug Exposure During Pregnancy
107 (.23%)
Haemodialysis
106 (.22%)
Shock
106 (.22%)
Oxygen Saturation Decreased
105 (.22%)
Psychotic Disorder
105 (.22%)
Bradycardia
104 (.22%)
Disseminated Intravascular Coagulat...
104 (.22%)
Leukopenia
104 (.22%)
Heart Rate Increased
101 (.21%)
Peritonitis
101 (.21%)
Rotator Cuff Syndrome
100 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Methylprednisolone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Methylprednisolone

What are the most common Methylprednisolone adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Methylprednisolone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Methylprednisolone According to Those Reporting Adverse Events

Why are people taking Methylprednisolone, according to those reporting adverse events to the FDA?

Premedication
1597
Rheumatoid Arthritis
1115
Drug Use For Unknown Indication
1040
Product Used For Unknown Indication
878
Multiple Sclerosis
643
Renal Transplant
637
Show More Show More
Immunosuppression
412
Asthma
372
Prophylaxis
276
Prophylaxis Against Transplant Reje...
259
Prophylaxis Against Graft Versus Ho...
258
Multiple Sclerosis Relapse
247
Liver Transplant
241
Graft Versus Host Disease
219
Ill-defined Disorder
182
Interstitial Lung Disease
174
Acute Lymphocytic Leukaemia
173
Systemic Lupus Erythematosus
153
Chronic Obstructive Pulmonary Disea...
128
Immunosuppressant Drug Therapy
127
Crohns Disease
122
Pain
119
Non-hodgkins Lymphoma
110
Arthritis
105
Nephrotic Syndrome
97
Lupus Nephritis
96
Juvenile Arthritis
96
Inflammation
95
Back Pain
95
Pneumonia
88
Colitis Ulcerative
88
Hypersensitivity
85
Transplant Rejection
84
Lymphoma
80
Dermatomyositis
80
Chronic Lymphocytic Leukaemia
75
Lung Transplant
70
Arthralgia
68
Bronchitis
63
Breast Cancer Metastatic
63
Aplastic Anaemia
62
Acute Graft Versus Host Disease
62
Prophylaxis Of Nausea And Vomiting
62
Wegeners Granulomatosis
59
Dyspnoea
57
B-cell Lymphoma
56
Diffuse Large B-cell Lymphoma
56
Kidney Transplant Rejection
53
Rash
52
Multiple Myeloma
51
Vasculitis
50

Drug Labels

LabelLabelerEffective
MethylprednisoloneRebel Distributors Corp.01-JUN-09
MethylprednisolonePhysicians Total Care, Inc.26-OCT-09
Methylprednisolone Sodium SuccinateBedford Laboratories08-DEC-09
Methylprednisolone Sodium SuccinateBedford Laboratories08-DEC-09
Depo-medrolPharmacia and Upjohn Company30-MAR-10
Depo-medrolPharmacia and Upjohn Company19-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
Depo-medrolPhysicians Total Care, Inc.20-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
MedrolPharmacia and Upjohn Company27-APR-10
MethylprednisoloneAltura Pharmaceuticals, Inc.28-APR-10
MethylprednisoloneGreenstone LLC06-MAY-10
MethylprednisoloneKeltman Pharmaceuticals Inc.10-AUG-10
MethylprednisoloneTeva Parenteral Medicines, Inc15-SEP-10
Methylprednisolone AcetateRebel Distributors Corp17-JAN-11
MethylprednisolonePhysicians Total Care, Inc.31-MAR-11
MethylprednisoloneUnit Dose Services31-MAR-11
Methylprednisolone JUBILANT CADISTA PHARMACEUTICALS, INC.31-MAR-11
Depo-medrolRebel Distributors Corp28-JUN-11
MethylprednisoloneDispensing Solutions, Inc.22-SEP-11
Methylprednisolone AcetateSandoz Inc20-OCT-11
MethylprednisoloneQualitest Pharmaceuticals16-JAN-12
Depo-medrolDispensing Solutions, Inc.01-FEB-12
MethylprednisoloneBreckenridge Pharmaceutical, Inc.02-FEB-12
MethylprednisoloneLake Erie Medical & Surgical Supply DBA Quality Care Products LLC09-FEB-12
MethylprednisoloneREMEDYREPACK INC. 01-MAR-12
MethylprednisoloneSTAT Rx USA LLC16-MAR-12
MethylprednisoloneSandoz Inc26-MAR-12
Solu-medrolCardinal Health03-MAY-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company02-JUL-12
MethylprednisoloneREMEDYREPACK INC. 10-JUL-12
Solu-medrolCardinal Health13-JUL-12
MethylprednisoloneSTAT Rx USA LLC17-JUL-12
Depo-medrolCardinal Health06-AUG-12
Methylprednisolone AcetateTeva Parenteral Medicines, Inc.11-AUG-12
MethylprednisoloneLake Erie Medical DBA Quality Care Products LLC23-AUG-12
Methylprednisolone AcetatePhysicians Total Care, Inc.29-AUG-12
Methylprednisolone Sodium SuccinateAPP Pharmaceuticals, LLC31-AUG-12
Methylprednisolone Sodium SuccinateAPP Pharmaceuticals, LLC31-AUG-12
MethylprednisoloneREMEDYREPACK INC. 05-SEP-12
Methylprednisolone KAISER FOUNDATION HOSPITALS18-SEP-12
Solu-medrolREMEDYREPACK INC. 09-FEB-13
Methylprednisolone Bryant Ranch Prepack13-FEB-13
MedrolREMEDYREPACK INC. 19-FEB-13
Methylprednisolone Sodium SuccinateCardinal Health13-MAR-13
Methylprednisolone AcetateSandoz Inc18-MAR-13
Solu-medrolCardinal Health20-MAR-13
MethylprednisoloneGreenstone LLC25-MAR-13
Solu-medrolCardinal Health04-APR-13
Depo-medrolREMEDYREPACK INC. 10-APR-13
Solu-medrolREMEDYREPACK INC. 15-APR-13
MedrolPharmacia and Upjohn Company17-APR-13
Depo-medrolPharmacia and Upjohn Company24-APR-13

Methylprednisolone Case Reports

What Methylprednisolone safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Methylprednisolone. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Methylprednisolone.